Asset
Tuvutromstat
IDEAYA Biosciences Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07277413 | phase1 | recruiting | 2026-03-04 | 2028-04-30 | IDEAYA Biosciences | A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors |
| NCT04794699 | phase1 | active_not_recruiting | 2021-04-14 | 2027-01-07 | IDEAYA Biosciences | Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion |
FDA applications (0)
This company has no applications containing this asset.